Modeling Pharmaceutical Powder-Flow Performance Using Particle-Size Distribution Data - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Modeling Pharmaceutical Powder-Flow Performance Using Particle-Size Distribution Data
The authors present a simple and material-sparing approach for estimating the powder-flow performance of previously uncharacterized single-component bulk powders when only particle-size distribution data are available.


Pharmaceutical Technology
Volume 33, Issue 3, pp. 126-134

Results

PLS modeling. PLS regression analysis method was used to develop a model to predict the FFC value from the PSD statistics for each material type. A single model to describe all material types could not predict the FFC value as well as a model built for a single material type. Therefore, separate models were built for active blends, active granulations, excipients, and APIs. This is not surprising considering the shape of the PSD curves and their response to shear stresses can be quite different across material types; for example, single component systems are typically uni-modal, but granulations are typically polymodal.

The authors developed a four-parameter model using the most commonly reported PSD statistics for each material type to predict the FFC value from the PSD statistics, as shown below.

FFC = exp(b 0 + b 1 ln D10 + b 2 ln D50 + b 3 ln D90 + b 4 ln D[4,3])


Figure 1 (FIGURES ARE COURTESY OF THE AUTHORS.)
A plot of the measured versus predicted FFC value for each material type is shown in Figure 1. Visual inspection of these plots suggests that the predictions for the API and excipient FFC values are superior to the active blends and active granulations. The R 2 values in Table I describe the quality of the fit of linear regressions through the data in Figure 1 and, therefore, confirm this observation. The R 2 values for the API and excipient models were 0.93 and 0.79, respectively, suggesting good model fits. The R 2 values for the active blends and active granulations were all <0.32, suggesting that the models were not able to describe the flow performance of these materials using particle-size data with the same level of confidence. These results suggests that PSD statistics alone in the PLS models are more appropriate for predicting the flow performance of single component APIs or excipients. The models, however, may be useful for investigating potential differences in flow performance for like-composition formulations that have been subjected to different manufacturing process conditions.

Tree-based classification model. A tree-based classification approach was used to categorize flow performance of the powders based on the relevant PSD statistics. The literature has reported similar rules of thumb for estimating flow behavior from particle size. For example, Staniforth reports that particles larger than 250 μm are usually free flowing; particles smaller than 100 μm become cohesive; and particles less than 10 μm are extremely cohesive (2). This statistical method selects the particle size parameters that are most significant in describing or categorizing the flow performance. The tree-based model was generated from the data using four parameters of the PSD: D10, D50, D90, and D[4,3].


Figure 2
The classification tree results in Figure 2 show that, for both models, only two distribution statistics were significant when predicting the flow category: the D10 and 50. These results further support the hypothesis formed in the PLS discussion that models that use PSD statistics to predict powder flow do not require (or cannot be any better predicted by) a multitude of parameters. These models are probably the most useful for forming "rules of thumb" when using PSD data to predict powder-flow performance. When higher resolution flow characterization is required, the PLS model described above or measuring the flow performance of the powder is preferred.


Figure 3
Testing the models. To investigate the predictive power of the PLS model, the authors evaluated the PSD and powder-flow performance of additional powder samples to test the predictions. Data from these materials were not used for the development of these models. In most cases, the models predicted the FFC value within the same flow category (excellent, good, marginal, poor) as the measured value (see Figure 3). Case 2 was an exception. In this case, the active blend contained an unusually high proportion of fines (D10=4 μm) because of a 25% loading of an API with a median diameter of 10 μm. Even with this discrepancy, however, a simplified set of PSD statistics (i.e., D10, D50, D90, D[4,3]) was found to suitably predict an estimated FFC on average to plus or minus one FFC unit for these newly characterized materials.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
14%
To select process for new products only
23%
To select processes for both new and legacy products
20%
Do not use QbD
25%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here